These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 17040216)
1. Increased susceptibility to phenytoin teratogenicity: excessive generation of reactive oxygen species or impaired antioxidant defense? Azarbayjani F; Borg LA; Danielsson BR Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):305-11. PubMed ID: 17040216 [TBL] [Abstract][Full Text] [Related]
2. Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity. Winn LM; Wells PG Mol Pharmacol; 1995 Jul; 48(1):112-20. PubMed ID: 7623765 [TBL] [Abstract][Full Text] [Related]
3. Initiation of phenytoin teratogenesis: pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation. Danielsson BR; Azarbayjani F; Sköld AC; Webster WS Teratology; 1997 Oct; 56(4):271-81. PubMed ID: 9408978 [TBL] [Abstract][Full Text] [Related]
4. Embryoprotective role of endogenous catalase in acatalasemic and human catalase-expressing mouse embryos exposed in culture to developmental and phenytoin-enhanced oxidative stress. Abramov JP; Wells PG Toxicol Sci; 2011 Apr; 120(2):428-38. PubMed ID: 21252394 [TBL] [Abstract][Full Text] [Related]
5. Antioxidant and GSH-related enzyme response to a single teratogenic exposure to the anticonvulsant phenytoin: temporospatial evaluation. Amicarelli F; Tiboni GM; Colafarina S; Bonfigli A; Iammarrone E; Miranda M; Di Ilio C Teratology; 2000 Aug; 62(2):100-7. PubMed ID: 10931507 [TBL] [Abstract][Full Text] [Related]
6. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant. Liu L; Wells PG Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459 [TBL] [Abstract][Full Text] [Related]
7. In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis. Liu L; Wells PG Toxicol Appl Pharmacol; 1994 Apr; 125(2):247-55. PubMed ID: 8171432 [TBL] [Abstract][Full Text] [Related]
8. Polytherapy with hERG-blocking antiepileptic drugs: increased risk for embryonic cardiac arrhythmia and teratogenicity. Danielsson C; Azarbayjani F; Sköld AC; Sjögren N; Danielsson BR Birth Defects Res A Clin Mol Teratol; 2007 Aug; 79(8):595-603. PubMed ID: 17584909 [TBL] [Abstract][Full Text] [Related]
9. Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage. Danielsson BR; Skold AC; Azarbayjani F Curr Pharm Des; 2001 Jun; 7(9):787-802. PubMed ID: 11375779 [TBL] [Abstract][Full Text] [Related]
10. Effect of phenytoin on maternal heart rate in A/J mice: possible role in teratogenesis. Watkinson WP; Millicovsky G Teratology; 1983 Aug; 28(1):1-8. PubMed ID: 6635988 [TBL] [Abstract][Full Text] [Related]
11. Phenytoin-induced cleft palate: evidence for embryonic cardiac bradyarrhythmia due to inhibition of delayed rectifier K+ channels resulting in hypoxia-reoxygenation damage. Azarbayjani F; Danielsson BR Teratology; 2001 Mar; 63(3):152-60. PubMed ID: 11283972 [TBL] [Abstract][Full Text] [Related]
12. Modulation of embryonic glutathione peroxidase activity and phenytoin teratogenicity by dietary deprivation of selenium in CD-1 mice. Ozolins TR; Siksay DL; Wells PG J Pharmacol Exp Ther; 1996 May; 277(2):945-53. PubMed ID: 8627577 [TBL] [Abstract][Full Text] [Related]
13. Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs. Danielsson BR; Danielsson C; Nilsson MF Reprod Toxicol; 2007 Jul; 24(1):42-56. PubMed ID: 17570632 [TBL] [Abstract][Full Text] [Related]
14. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis. Winn LM; Wells PG Free Radic Biol Med; 1997; 22(4):607-21. PubMed ID: 9013124 [TBL] [Abstract][Full Text] [Related]
15. Modulation of embryonic glutathione reductase and phenytoin teratogenicity by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Wong M; Wells PG J Pharmacol Exp Ther; 1989 Jul; 250(1):336-42. PubMed ID: 2746506 [TBL] [Abstract][Full Text] [Related]
16. Dose dependent effect of ricin on DNA damage and antioxidant enzymes in mice. Kumar O; Lakshmana Rao PV; Pradhan S; Jayaraj R; Bhaskar AS; Nashikkar AB; Vijayaraghavan R Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):92-102. PubMed ID: 17543238 [TBL] [Abstract][Full Text] [Related]
17. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Ornoy A Reprod Toxicol; 2007 Jul; 24(1):31-41. PubMed ID: 17548185 [TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species contribute to lipopolysaccharide-induced teratogenesis in mice. Zhao L; Chen YH; Wang H; Ji YL; Ning H; Wang SF; Zhang C; Lu JW; Duan ZH; Xu DX Toxicol Sci; 2008 May; 103(1):149-57. PubMed ID: 18281254 [TBL] [Abstract][Full Text] [Related]
19. The development of antioxidant defense mechanism in young rat embryos in vivo and in vitro. Zaken V; Kohen R; Ornoy A Early Pregnancy (Cherry Hill); 2000 Apr; 4(2):110-23. PubMed ID: 11723541 [TBL] [Abstract][Full Text] [Related]
20. Evidence for Ras-dependent signal transduction in phenytoin teratogenicity. Winn LM; Wells PG Toxicol Appl Pharmacol; 2002 Nov; 184(3):144-52. PubMed ID: 12460742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]